Summary
47 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $19.2M against $17.0M.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 88% this fiscal year.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Is it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
For the next fiscal year analysts expect revenue to fall by 88%.
Growth in detailDoes it make money?
Over the last 12 months it made a loss of $42.6M.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 10
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $11.83 is 576% above today's price. 91% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Reportable Segment 100%
By region
The company reports no revenue by region.
Reportable Segment brings in 100% of revenue.
Segments in detail